########################################
# Program: needle
# Rundate: Wed 30 May 2018 14:29:59
# Commandline: needle
#    -outfile /Users/teresatavella/Documents/models_new/seqid30_85/gb_WP_038583059_ARO_3003778_Mycobacterium_5wed_A/needle.txt
#    -asequence /Users/teresatavella/Documents/models_new/seqid30_85/gb_WP_038583059_ARO_3003778_Mycobacterium_5wed_A/gb_WP_038583059_ARO_3003778_Mycobacterium_smegmatis_mutant_ndh_conferring_resistance_to_isoniazid__Mycobacterium_smegmatis.fa
#    -bsequence /Users/teresatavella/Documents/models_new/seqid30_85/gb_WP_038583059_ARO_3003778_Mycobacterium_5wed_A/5wed_A.fa
#    -gapopen 10
#    -gapextend 0.5
# Align_format: srspair
# Report_file: /Users/teresatavella/Documents/models_new/seqid30_85/gb_WP_038583059_ARO_3003778_Mycobacterium_5wed_A/needle.txt
########################################

#=======================================
#
# Aligned_sequences: 2
# 1: gb_WP_038583059_ARO_3003778_Mycobacterium_smegmatis_mutant_ndh_conferring_resistance_to_isoniazid__Mycobacterium_smegmatis
# 2: 5wed_A_mol_protein_length_405__FAD-dependent_pyridine_nucleotide-disulfide_oxidoreductase
# Matrix: EBLOSUM62
# Gap_penalty: 10.0
# Extend_penalty: 0.5
#
# Length: 469
# Identity:     127/469 (27.1%)
# Similarity:   206/469 (43.9%)
# Gaps:          87/469 (18.6%)
# Score: 418.0
# 
#
#=======================================

gb_WP_0385830      1 MSHPGATASDRHKVVIIGSGFGGLTAA----KTLKRADVDVKLIARTTHH     46
                               :..:||:|:|:||:.||    |.|...:.|:.|:.:..:|
5wed_A_mol_pr      1 ----------KPSIVILGAGYGGIVAALGLQKRLNYNEADITLVNKNDYH     40

gb_WP_0385830     47 LFQPLLYQVATGIISEGEIAPATRVILRKQKNAQVLLCDVTHIDLENKTV     96
                     .....|:|.|.|.:...:.....:.:: .:|..:.:...|..||.|.:.|
5wed_A_mol_pr     41 YITTELHQPAAGTMHHDQARVGIKELI-DEKKIKFVKDTVVAIDREQQKV     89

gb_WP_0385830     97 DSVLLGHTYSTPYDSLIIAAGAGQSYFGNDHFAEFAPGMKSIDDALELRG    146
                      ::..|..:   ||.|::..|:....||.:...|.|..:.||:....:|.
5wed_A_mol_pr     90 -TLQNGELH---YDYLVVGLGSEPETFGIEGLREHAFSINSINSVRIIRQ    135

gb_WP_0385830    147 RILGAFEQAERSSDPVRRAKLLTFTVVGAGPTGVEMAGQIAELADQTLRG    196
                     .|  .::.|:.:::| .|...||..|.|||.||:|..|::|:...: |..
5wed_A_mol_pr    136 HI--EYQFAKFAAEP-ERTDYLTIVVGGAGFTGIEFVGELADRMPE-LCA    181

gb_WP_0385830    197 SFRHIDPTEARVILLDAAPAVLPPMGEKLGKKARARLEKMGVEVQLGAMV    246
                     .: .:||...|:|.::|||.|||.....|...|...|...|||.::|..:
5wed_A_mol_pr    182 EY-DVDPKLVRIINVEAAPTVLPGFDPALVNYAMDVLGGKGVEFKIGTPI    230

gb_WP_0385830    247 TDVDRNGITVKDSDGTIRRIESACKVWSAGVSASPLGKDLAEQSGVELDR    296
                     ......|:.: :.||....|::|..||:.||.    |..:.|:||.|..|
5wed_A_mol_pr    231 KRCTPEGVVI-EVDGEEEEIKAATVVWTGGVR----GNSIVEKSGFETMR    275

gb_WP_0385830    297 AGRVKVQPDLTLPGHPNVFVVGDMAAV------EGVPGVAQGAIQGGRYA    340
                      ||:||.|.|..|||.|:|:|||.|.:      ...|..||.|||.|...
5wed_A_mol_pr    276 -GRIKVDPYLRAPGHENIFIVGDCALIINEENNRPYPPTAQIAIQHGENV    324

gb_WP_0385830    341 AKIIKREVSGTSPKIRTPFEYFDKGSMATVSRFSAVAKVGPVEFAGFFA-    389
                     |..:...:.|.|   .|||:...:|::|::.|..|:..||..:..|..| 
5wed_A_mol_pr    325 AANLAALIRGGS---MTPFKPHIRGTVASLGRNDAIGIVGGRKVYGHAAS    371

gb_WP_0385830    390 WLCWLV-LHLVYLVGFKTKIVTLLSWGVTFLSTKRGQLTITEQQAYARTR    438
                     ||..|: :..:||:|           |::.:..|                
5wed_A_mol_pr    372 WLKKLIDMRYLYLIG-----------GLSLVLKK----------------    394

gb_WP_0385830    439 IEELEEIAAAVQDTEKAAS    457
                                        
5wed_A_mol_pr    394 -------------------    394


#---------------------------------------
#---------------------------------------